Trans fatty acids influence the oxidation of LDL in ECV304 cells

European Journal of Lipid Science and Technology

Volumn 114, Issue 8, 2012, Pages 880-888

  Zhi, Tan ^a   Yanhong, Liu ^b   Rui, Liang ^a   Jian, Song ^a   Jinping, Liu ^c   Junzhu, Wu ^a  

^a WUHAN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c JINGCHU UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Endothelial cells; HNP 1; LDL; Oxidation; Trans fatty acid

Indexed keywords

EID: 84865289459     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201100292     Document Type: Article

References (28)

1. Lichtenstein, A. H., Dietary trans fatty acid. J. Cardiopulm. Rehabil. 2000, 20, 143- 146.
2. Emken, E. A., Nutrition and biochemistry of trans and positional fatty acid isomers in hydrogenated oils. Annu. Rev. Nutr. 1984, 4, 339- 376.
3. Brouwer, I. A., Wanders, A. J., Katan, M. B., Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans-α quantitative review. PLoS One 2010, 5, e9434.
4. Mozaffarian, D., Trans fatty acids - effects on systemic inflammation and endothelial function. Atheroscler. Suppl. 2006, 7, 29- 32.
5. Ghahremanpour, F., Firoozrai, M., Darabi, M., Zavarei, A., Mohebbi, A., Adipose tissue trans fatty acids and risk of coronary artery disease: A case-control study. Ann. Nutr. Metab. 2008, 52, 24- 28.
6. Lemaitre, R. N., King, I. B., Raghunathan, T. E., Pearce, R. M. et al., Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 2002, 105, 697- 701.
7. Mozaffarian, D., Rimm, E. B., King, I. B., Lawler, R. L. et al., Trans fatty acids and systemic inflammation in heart failure. Am. J. Clin. Nutr. 2004, 80, 1521- 1525.
8. Kummerow, F. A., The negative effects of hydrogenated trans fats and what to do about them. Atherosclerosis 2009, 205, 458- 465.
9. Harvey, K. A., Arnold, T., Rasool, T., Antalis, C. et al., Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. Br. J. Nutr. 2007, 99.
10. Landmesser, U., Hornig, B., Drexler, H., Endothelial function: A critical determinant in atherosclerosis? Circulation 2004, 109, II27- II33.
11. Behrendt, D., Ganz, P., Endothelial function. From vascular biology to clinical applications. Am. J. Cardiol. 2002, 90, 40L- 48L.
12. Zapolska-Downar, D., Kosmider, A., Naruszewicz, M., Trans fatty acids induce apoptosis in human endothelial cells. J. Physiol. Pharmacol. 2005, 56, 611- 625.
13. Singh, U., Jialal, I., Oxidative stress and atherosclerosis. Pathophysiology 2006, 13, 129- 142.
14. Yoshida, H., Kisugi, R., Mechanisms of LDL oxidation. Clin. Chim. Acta 2010, 411, 1875- 1882.
15. Fen, D., Lingyan, P., Chunyan, H., Hong, Y. et al., Involvement of HNP-1 in different oxidation mechanisms in human endothelial cells. Eur. J. Lipid Sci. Technol. 2011, 113, 430- 435.
16. He, C., Huang, R., Du, F., Zheng, F. et al., LDL oxidation by THP-1 monocytes: Implication of HNP-1, SgIII and DMT-1. Clin. Chim. Acta 2009, 402, 102- 106.
17. Suda, K., Rothen-Rutishauser, B., Gunthert, M., Wunderli-Allenspach, H., Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: Endothelial versus epithelial features. In Vitro Cell. Dev. Biol. Anim. 2001, 37, 505- 514.
18. Levine, R. L., Garland, D., Oliver, C. N., Amici, A. et al., Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186, 464- 478.
19. Ascherio, A., Katan, M. B., Zock, P. L., Stampfer, M. J., Willett, W. C., Trans fatty acids and coronary heart disease. N. Engl. J. Med. 1999, 340, 1994- 1998.
20. Judd, J. T., Clevidence, B. A., Muesing, R. A., Wittes, J. et al., Dietary trans fatty acids: Effects on plasma lipids and lipoproteins of healthy men and women. Am. J. Clin. Nutr. 1994, 59, 861- 868.
21. Lichtenstein, A. H., Ausman, L. M., Jalbert, S. M., Schaefer, E. J., Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N. Engl. J. Med. 1999, 340, 1933- 1940.
22. Mensink, R. P., Katan, M. B., Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N. Engl. J. Med. 1990, 323, 439- 445.
23. de Roos, N., Schouten, E., Katan, M., Consumption of a solid fat rich in lauric acid results in a more favorable serum lipid profile in healthy men and women than consumption of a solid fat rich in trans-fatty acids. J. Nutr. 2001, 131, 242- 245.
24. Katan, M. B., Trans fatty acids and plasma lipoproteins. Nutr. Rev. 2000, 58, 188- 191.
25. Bassett, C. M., McCullough, R. S., Edel, A. L., Maddaford, T. G. et al., Trans-fatty acids in the diet stimulate atherosclerosis. Metabolism 2009, 58, 1802- 1808.
26. Gebauer, S. K., Psota, T. L., Kris-Etherton, P. M., The diversity of health effects of individual trans fatty acid isomers. Lipids 2007, 42, 787- 799.
27. Bassett, C. M. C., Edel, A. L., Patenaude, A. F., McCullough, R. S. et al., Dietary vaccenic acid has antiatherogenic effects in LDLr-/- mice. J. Nutr. 2009, 140, 18- 24.
28. Niki, E., Do free radicals play causal role in atherosclerosis? Low density lipoprotein oxidation and vitamin E revisited. J. Clin. Biochem. Nutr. 2011, 48, 3- 7.